Annual report
2931.TEDINET S100QG7X
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 64
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥34.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | −¥3.5bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | −¥6.6bn | 2020-10-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥6.4bn | 2020-10-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | −¥2.4bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥6.7bn | 2020-10-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥5.0bn | 2020-10-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | −¥5.8bn | 2020-10-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥57.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥61.0bn | at 2021-12-31 | Cons. | Assets |
| Total liabilities | ¥37.9bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥40.4bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2021-12-31 | Cons. | Net assets |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.9bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥924m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥1.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.3bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥12.1bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.07 | 2020-10-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥167.34 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥181.35 | at 2021-12-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 865 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 883 | at 2021-12-31 | Cons. | Number of employees |
| Revenue | ¥6.5bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥9.5bn | 2020-10-01 → 2021-12-31 | Standalone | Net sales |
| Operating income | −¥3.5bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | −¥3.4bn | 2020-10-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | −¥2.2bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥2.6bn | 2020-10-01 → 2021-12-31 | Standalone | Ordinary income |
| Profit before tax | −¥2.6bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥2.7bn | 2020-10-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | −¥2.7bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥2.4bn | 2020-10-01 → 2021-12-31 | Standalone | Profit loss |
| Total assets | ¥26.7bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥27.8bn | at 2021-12-31 | Standalone | Assets |
| Total liabilities | ¥5.2bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥5.5bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥21.5bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥22.3bn | at 2021-12-31 | Standalone | Net assets |
| Cash and deposits | ¥2.9bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.9bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-23.9 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.94 | 2020-10-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥186.11 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥197.18 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 113,105,455 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 111,161,886 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Employees | 250 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 212 | at 2021-12-31 | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥1m |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥50m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥3.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥1.7bn |
| Biofuel Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥22m |
| Biofuel Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥49m |
| Biofuel Businessreportable segment | employees | at 2022-12-31 | 43 pure |
| Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥262m |
| Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥262m |
| Biofuel Businessreportable segment | segment assets | at 2022-12-31 | ¥947m |
| Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥789m |
| Health Care Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥406m |
| Health Care Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥2.2bn |
| Health Care Businessreportable segment | employees | at 2022-12-31 | 655 pure |
| Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥41.6bn |
| Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥41.6bn |
| Health Care Businessreportable segment | segment assets | at 2022-12-31 | ¥49.6bn |
| Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥638m |
| Others Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥48m |
| Others Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥34m |
| Others Businessreportable segment | employees | at 2022-12-31 | 113 pure |
| Others Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Others Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Others Businessreportable segment | segment assets | at 2022-12-31 | ¥3.3bn |
| Others Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥325m |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥477m |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥2.3bn |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥44.4bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥44.4bn |
| —segment total | segment assets | at 2022-12-31 | ¥53.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | −¥1.8bn |
| Reconciling Itemsreconciling | capex | 2020-10-01 → 2021-12-31 | ¥31m |
| Reconciling Itemsreconciling | depreciation | 2020-10-01 → 2021-12-31 | ¥94m |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | ¥5.7bn |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-12-31 | −¥2.2bn |
| Biofuel Businessreportable segment | capex | 2020-10-01 → 2021-12-31 | ¥37m |
| Biofuel Businessreportable segment | depreciation | 2020-10-01 → 2021-12-31 | ¥110m |
| Biofuel Businessreportable segment | revenue | 2020-10-01 → 2021-12-31 | ¥47m |
| Biofuel Businessreportable segment | revenue external | 2020-10-01 → 2021-12-31 | ¥47m |
| Biofuel Businessreportable segment | segment assets | at 2021-12-31 | ¥602m |
| Biofuel Businessreportable segment | segment profit | 2020-10-01 → 2021-12-31 | −¥1.2bn |
| Health Care Businessreportable segment | capex | 2020-10-01 → 2021-12-31 | ¥387m |
| Health Care Businessreportable segment | depreciation | 2020-10-01 → 2021-12-31 | ¥1.5bn |
| Health Care Businessreportable segment | revenue | 2020-10-01 → 2021-12-31 | ¥33.7bn |
| Health Care Businessreportable segment | revenue external | 2020-10-01 → 2021-12-31 | ¥33.7bn |
| Health Care Businessreportable segment | segment assets | at 2021-12-31 | ¥52.1bn |
| Health Care Businessreportable segment | segment profit | 2020-10-01 → 2021-12-31 | −¥2.8bn |
| Others Businessreportable segment | capex | 2020-10-01 → 2021-12-31 | ¥54m |
| Others Businessreportable segment | depreciation | 2020-10-01 → 2021-12-31 | ¥14m |
| Others Businessreportable segment | revenue | 2020-10-01 → 2021-12-31 | ¥627m |
| Others Businessreportable segment | revenue external | 2020-10-01 → 2021-12-31 | ¥627m |
| Others Businessreportable segment | segment assets | at 2021-12-31 | ¥2.6bn |
| Others Businessreportable segment | segment profit | 2020-10-01 → 2021-12-31 | −¥373m |
| —segment total | capex | 2020-10-01 → 2021-12-31 | ¥479m |
| —segment total | depreciation | 2020-10-01 → 2021-12-31 | ¥1.6bn |
| —segment total | revenue | 2020-10-01 → 2021-12-31 | ¥34.4bn |
| —segment total | revenue external | 2020-10-01 → 2021-12-31 | ¥34.4bn |
| —segment total | segment assets | at 2021-12-31 | ¥55.3bn |
| —segment total | segment profit | 2020-10-01 → 2021-12-31 | −¥4.4bn |
| Biofuel Businessreportable segment | employees | at 2022-12-31 | 43 pure |
| Health Care Businessreportable segment | employees | at 2022-12-31 | 127 pure |
| Others Businessreportable segment | employees | at 2022-12-31 | 25 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,625
| Item | Context | Value | Unit |
|---|---|---|---|
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary disposed of by sales of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration | Text · Plus | |
| Information for each product or service (text) | Prior1YearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of asset retirement obligations (text) | CurrentYearDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |